P78 Patients over 80 years of age with de novo AML, normal karyotype, and without erythroblastic and/or megakaryocytic dysplasia may reach complete remission and better survival after standard dose chemotherapy

• 作者P. Lemez; J. Galikova; K. Michalova; A. MacWhannell; D. Dvorakova; Z. Zemanova; J. Stejskal
• 卷第72卷
• 印刷ISSN1040-8428
• 文件大小59.42KB
• 发表时间2009
• DOI10.1016/s1040-8428(09)70116-7